These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9118466)

  • 41. Mitotane treatment for adrenocortical carcinoma: an overview.
    De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
    Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma.
    Schteingart DE; Sinsheimer JE; Counsell RE; Abrams GD; McClellan N; Djanegara T; Hines J; Ruangwises N; Benitez R; Wotring LL
    Cancer Chemother Pharmacol; 1993; 31(6):459-66. PubMed ID: 8453685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of high density lipoproteins in the biodistribution of two radioiodinated probes in the rat.
    Pohland RC; Counsell RE
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):47-57. PubMed ID: 3966242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitotane (1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane) metabolism in perfusion studies with dog adrenal glands.
    Sinsheimer JE; Freeman CJ
    Drug Metab Dispos; 1987; 15(2):267-9. PubMed ID: 2882989
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gas chromatographic-electron capture determination of 2,4'-dichlorodiphenylacetic acid from in-vitro adrenal transformations of mitotane and its analogs.
    Sinsheimer JE; Counsell RE; Cai W; Gopalaswamy R; Mahalakshmi P; Piñeiro-Sánchez ML; Ruangwises N; Schteingart DE
    J Pharm Biomed Anal; 1996 May; 14(7):861-6. PubMed ID: 8809711
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro macromolecular binding of 2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) in the mouse lung and liver.
    Lund BO; Bergman A; Brandt I
    Chem Biol Interact; 1989; 70(1-2):63-72. PubMed ID: 2736677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Covalent binding of o,p'-DDD in rabbit lung and isolated rabbit lung cells.
    Lund BO; Becher R; Låg M; Dahl JE
    Toxicol Lett; 1990 Oct; 53(3):297-306. PubMed ID: 2237936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography.
    Andersen A; Kasperlik-Zaluska AA; Warren DJ
    Ther Drug Monit; 1999 Jun; 21(3):355-9. PubMed ID: 10365653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma.
    Kroiss M; Quinkler M; Lutz WK; Allolio B; Fassnacht M
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):585-91. PubMed ID: 21883349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and therapeutic observations in the adrenal cancer: a report on 7 patients treated with o,p'-DDD.
    MOLNAR GD; MATTOX VR; BAHN RC
    Cancer; 1963 Feb; 16():259-68. PubMed ID: 13935915
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of o,p'-DDE, a Mitotane Metabolite, in an Adrenocortical Carcinoma Cell Line.
    Bach C; Corso CR; Veiga AA; Paraizo MM; de Souza LM
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-free synthesis and characterization of human adrenocortical pro-adrenodoxin.
    Pascal O; Monnier N; Chambaz EM
    Biochem Biophys Res Commun; 1986 Apr; 136(1):348-55. PubMed ID: 2423079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome P-450 transfer from adrenocortical submitochondrial particles to liposome membranes.
    Kominami S; Onizuka M; Tasaka-Marumoto C; Takemori S
    Biochemistry; 1995 Apr; 34(14):4839-45. PubMed ID: 7718590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.
    Germano A; Rapa I; Volante M; De Francia S; Migliore C; Berruti A; Papotti M; Terzolo M
    Mol Cell Endocrinol; 2015 Feb; 401():105-10. PubMed ID: 25497672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary culture system of adrenocortical cells from dogs to evaluate direct effects of chemicals on steroidogenesis.
    Morishita K; Okumura H; Ito N; Takahashi N
    Toxicology; 2001 Aug; 165(2-3):171-8. PubMed ID: 11522375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irreversible binding of o,p'-DDD in interrenal cells of Atlantic cod (Gadus morhua).
    Lindhe O; Brandt I; Christiansen JS; Ingebrigtsen K
    Chemosphere; 2003 Mar; 50(9):1249-53. PubMed ID: 12547339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of o,p'-DDD therapy on plasma cholesterol in adrenal carcinoma.
    MOLNAR GD; NUNN SL; TAUXE WN
    Proc Staff Meet Mayo Clin; 1961 Nov; 36():618-20. PubMed ID: 14475247
    [No Abstract]   [Full Text] [Related]  

  • 59. O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.
    von Slooten H; van Seters AP; Smeenk D; Moolenaar AJ
    Cancer Chemother Pharmacol; 1982; 9(2):85-8. PubMed ID: 7172409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elimination of non-specific binding in western blots from non-reducing gels.
    Hanukoglu I
    J Biochem Biophys Methods; 1990 Jun; 21(1):65-8. PubMed ID: 2212467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.